Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study ; volume:19 ; number:1 ; day:5 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
BMC public health ; 19, Heft 1 (5.4.2019), 1-11, 12.2019
- Creator
-
Oetzel, John G.
Lao, Chunhuan
Morley, Michelle
Penman, Kathy
Child, Maree
Scott, Nina
Karalus, Miina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-019-6695-3
- URN
-
urn:nbn:de:101:1-2019042522390249555696
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oetzel, John G.
- Lao, Chunhuan
- Morley, Michelle
- Penman, Kathy
- Child, Maree
- Scott, Nina
- Karalus, Miina
- SpringerLink (Online service)
Other Objects (12)
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever